Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Estradiol and castration reduced prostate cancer development in rats when applied at early stages, but were ineffective after cancer was established.

Younger people (median age 35) experience more PFS-like symptoms with 1mg finasteride; more research needed.

Seven new genetic risk areas for prostate cancer were found.

A patient with a larger than usual genetic mutation had a broader range of symptoms for a muscle disease.

RNA-based treatments show promise for managing Hutchinson-Gilford Progeria Syndrome.

Certain genetic variants increase the risk of aggressive prostate cancer.

GSDMA deficiency slows skin cancer growth.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

PRP treatments and hair transplantation may be linked to the progression of pseudolymphoma to lymphoma.

VPS13C variants are linked to more severe REM sleep disorder and faster progression to Parkinson's disease.

TURP specimens should be checked for various tumors, not just common prostate issues.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

Low PON1 levels may indicate and predict the severity of hair loss.

Hutchinson-Gilford Progeria Syndrome causes rapid aging from a genetic mutation, with no cure but ongoing research into potential treatments.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

Finasteride may cause lasting sexual and mental health issues, and genetic screening could help prevent them.

The research found that Atypical Progeroid Syndrome has unique symptoms and is not caused by the buildup of a certain mutant protein.

Guselkumab significantly improves psoriasis symptoms within 12 weeks.

Certain genetic markers can indicate a person's risk of developing prostate cancer.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

Post-finasteride syndrome causes various symptoms in men using finasteride, with no known cure.

Men with untreated male pattern hair loss continue to lose hair over a 5-year period.

Certain maturity signs appear before and after the first release of sperm in boys.

Early baldness and little chest hair may indicate higher prostate cancer risk.

Androgen-driven traits don't predict prostate cancer recurrence.

Careful diagnosis is crucial in premature pubarche cases, as 20% have other conditions.

PCOS symptoms can improve with specific treatments for pituitary adenomas.

Prostate surgery is often effective long-term, but some patients may need more treatment or another surgery, especially if they had prostatitis before.

Gene therapy has potential as a future treatment for Hutchinson-Gilford progeria syndrome.

Men with enlarged prostates often have more severe baldness.